Complete Blood Count

A complete blood count (CBC) is a routine laboratory panel that measures the cellular components of blood: red blood cells, white blood cells and platelets, together with hemoglobin concentration, hematocrit and several derived indices. It is among the most frequently ordered blood tests, because a single small sample gives a broad picture of a person's blood and, indirectly, of the blood-forming system and the immune system.

The counts reflect how well the bone marrow is producing cells and how the body is responding to infection, inflammation, bleeding or disease, which is why anemia, infection, leukemia and clotting disorders can all be detected through it. The test has moved from manual counting under a microscope, first described in 1852, to automated analyzers that use electrical and optical methods to count and size cells in seconds. Automated results are still checked against blood smears when instruments flag unusual samples.

This entry first defines the test and its components, then covers the red cell indices, the white cell differential and platelet parameters. It goes on to trace the history and technology of cell counting, specimen handling and quality control, and the principles of reading results against age- and sex-specific reference intervals. The final sections address clinical uses, the tests that complement the CBC, and its current limitations and developments.

Definition and Components

What the panel measures

A complete blood count (CBC) is a standard laboratory panel. It consists of the red blood cell (RBC) count, white blood cell (WBC) count, and platelet count; measurement of hemoglobin and mean red cell volume; classification of white blood cells (WBC differential); and calculation of hematocrit and red blood cell indices. In routine practice the white cell differential is usually included, while the red cell indices are calculated from the primary measurements rather than counted directly.

A chemistry panel answers a different kind of question. It quantifies dissolved substances in plasma or serum, such as glucose, electrolytes, enzymes and lipids, whereas the CBC counts intact cells and measures the hemoglobin they contain. The two are often ordered together, but their measurements come from different physical components of the blood.

Units and what each value represents

Each parameter has its own unit. Red cell counts are usually given as the number of red blood cells in a certain amount of blood, usually a microliter (mcL), so they are expressed in millions per microliter. Hemoglobin is a concentration, reported in grams per deciliter, and it is the oxygen-binding protein inside red cells. Hematocrit is a fraction of volume: the percentage of blood by volume that is occupied by the red cells. Platelet and white cell counts are commonly quoted in thousands per microliter.

The International System of Units (SI) uses a different convention. Counts are expressed as cells per liter with a power of ten: the number of white blood cells can be expressed in international units of 10^9 cells per liter, or G/L (Giga = 1 billion). The conversion is direct, since $10^3/\mu\text{L} = 10^9/\text{L}$, so a value of 4.0 thousand per microliter equals $4.0 \times 10^9/\text{L}$. The reference range for adult white cells is therefore often stated as 4 to 11 x 10^9 cells/L.

Whole blood and fixed-volume counting

The CBC is performed on whole blood, meaning the cells together with the plasma in which they circulate. Plasma itself is not counted; instead, the instrument draws a measured aliquot of whole blood, dilutes it, and counts the particles passing through its sensing system. The result is a concentration per unit volume, not a total number of cells in the body. Because the reference is a fixed volume, the plasma fraction is implicitly part of every result, and hematocrit makes this relationship explicit by expressing red cells as a share of the whole-blood volume.

Clinical samples are normally venous, but small volumes are sufficient. For reference, one drop of blood is about 40 mcL to 50 mcL.

Why it is usually the first test, and its limits

The CBC is usually the first blood test ordered because it is fast, inexpensive and broadly informative. A single panel can reveal anemia, abnormal white cell levels suggestive of infection, inflammation or marrow disturbance, and low platelet counts that raise bleeding risk. For this reason it appears in routine check-ups, preoperative assessment and the investigation of many symptoms.

Its limits are equally important. A CBC does not identify the cause of an abnormality, does not confirm whether a raised white cell count reflects infection, and cannot assess clotting function, iron stores or the cellular detail of abnormal cells without further work. Reference ranges also depend on context: they are based on things that can affect your blood, like your age, your sex, and how high above sea level you live. Interpreting a result therefore requires the clinical picture and, when needed, a bone marrow or smear evaluation, both of which are discussed in later sections.

Red Blood Cell Parameters and Indices

The red cell part of a CBC rests on three closely related measurements. The red cell count gives the number of red blood cells per unit volume, hemoglobin concentration gives the mass of the oxygen-binding protein per unit volume, and hematocrit gives the fraction of the blood sample occupied by packed red cells. Hemoglobin binds oxygen in the lungs and releases it in tissues, so its concentration is the value most directly tied to the blood's capacity to carry oxygen, and it anchors the definition of anemia. Under normal conditions the three measures move together, but they can diverge when cells are abnormally small, large or pale. Hematocrit is in effect the product of cell number and average cell size, which is why a count alone cannot show whether a low hematocrit reflects few cells or small ones.

Maxwell Wintrobe introduced three calculated indices in 1929. Mean corpuscular volume (MCV) describes the average cell size in femtoliters. Mean corpuscular hemoglobin (MCH) gives the average hemoglobin mass per cell in picograms, and mean corpuscular hemoglobin concentration (MCHC) expresses hemoglobin relative to the volume of packed cells, in g/dL. Wintrobe worked from manual red counts, hemoglobin spectrophotometry and centrifuged packed-cell volumes, and the indices were derived by simple division of these values. In modern analyzers the process is reversed: the instrument measures cell volume directly, and hematocrit, MCH and MCHC are then computed from the counts and volumes. The formulas below give the traditional forms, with hemoglobin in g/dL, hematocrit in percent and red count in $10^{12}$/L:

Typical reference values are roughly 80–100 fL for MCV, 26–34 pg for MCH and 32–36 g/dL for MCHC, though exact limits differ among laboratories and methods. The old observation that hemoglobin is about one-third of hematocrit holds only when cells are of normal size and hemoglobin content, so departures from that ratio are themselves diagnostic information.

MCV is the main tool for sorting anemias by cell size. A value below the lower reference limit defines microcytic anemia, which is typical of iron deficiency and thalassemia trait. A value within the reference interval is normocytic, seen in acute blood loss, chronic disease and many early or mixed deficiencies. A value above the upper limit is macrocytic, associated with vitamin B12 or folate deficiency, alcohol use, liver disease and some drugs or marrow disorders. Red cell distribution width (RDW) complements MCV by measuring the variation in cell volume, usually as a coefficient of variation. A raised RDW signals anisocytosis, and when the MCV is normal it can hint at two coexisting red cell populations, because the average indices can conceal a mixture. Some analyzers also report an RDW standard-deviation form that does not depend on the mean volume. An elevated RDW is not specific to any one cause, so it is read together with MCV and clinical context.

Reference values for these parameters depend on sex and age. Adult men generally have higher hemoglobin than adult women, and in one pooled analysis the fifth centile was about 120 g/L in non-pregnant women aged 18–65 and about 135 g/L in men of the same age. The two sexes have similar thresholds until adolescence, after which male values run higher. Hemoglobin is high in the newborn period, falls during infancy and early childhood, and then climbs toward adult levels, while values in older adults are somewhat lower. Pregnancy also lowers the hemoglobin concentration by trimester, so pregnancy-specific cut-offs are used. These differences explain why the WHO anemia thresholds are set separately for men, women and children.

The patterns of common deficiencies illustrate how the indices are read together. Early iron deficiency often raises the RDW before hemoglobin falls, because new microcytic cells are produced alongside older normal cells. As stores are depleted, the typical profile becomes microcytic and hypochromic, with low MCV, MCH and MCHC. Serum ferritin is the usual confirmatory test, although it is an acute-phase reactant and can be misleading during inflammation. In vitamin B12 deficiency, impaired DNA synthesis in precursor cells produces large, poorly formed red cells with ineffective erythropoiesis. The typical result is a raised MCV, marked anisocytosis and a high RDW. When iron and B12 deficiencies coexist, the MCV can be normal or only modestly altered while the RDW remains high, which is one reason the RDW is valued alongside the indices rather than instead of them.

White Blood Cell Count and Differential

The total white blood cell (WBC) count, also called the total leukocyte count, measures the absolute number of all leukocytes in a fixed volume of blood. Reference ranges are often given per cubic millimeter or microliter, and in SI units as ×10^9 cells per liter. A typical adult range is about 4,000 to 10,000 per microliter, or 4.0 to 10 × 10^9/L, but limits vary by laboratory, age, sex and pregnancy status. Because the total adds every leukocyte together, a normal or abnormal total can hide opposite changes in different lineages. A rise in lymphocytes, for example, may be offset by a fall in neutrophils. Only the differential separates the total into its components.

The five normal leukocyte types

Neutrophils are the most abundant leukocytes and are the first responders to bacterial and fungal infection. They engulf and destroy microbes, and in adults they normally make up roughly 40% to 60% (or 55% to 70%, depending on the source) of the total. Lymphocytes usually form 20% to 40% of leukocytes. This group includes T cells, which mediate cellular immunity, and B cells, which produce antibodies; together they underpin adaptive-immunity and are central to the control of many viral infections. Monocytes, at about 2% to 8%, are large phagocytes that clear debris, present antigen and bridge innate-immunity with adaptive responses. Eosinophils, roughly 1% to 4%, are prominent in allergic reactions and in defense against many parasites. Basophils are the rarest, at about 0.5% to 1%, and contribute to allergic and inflammatory reactions through their granule contents. Neutrophils and lymphocytes together typically account for 75% to 90% of circulating leukocytes.

Relative and absolute counts

The differential is reported as a percentage of the total WBC and, in many laboratories, also as an absolute count. The absolute value is obtained by multiplying the percentage by the WBC: 30% lymphocytes in a sample with a WBC of 10,000 per microliter gives 3,000 lymphocytes per microliter. Absolute counts are generally more informative, because a normal percentage can conceal an abnormal absolute number when the total is markedly high or low. The absolute neutrophil count (ANC) and absolute lymphocyte count (ALC) are the most frequently used.

The differential also reports immature and abnormal cells. Band neutrophils, the immediate precursors of segmented neutrophils, are normally 0% to 3% of cells, and an increase is called a left shift, classically associated with bacterial infection. Band counts, however, are subjective and show considerable variation between observers; for this reason many laboratories have moved toward automated immature granulocyte (IG) counts, which include promyelocytes, myelocytes and metamyelocytes. Automated analyzers do not identify bands directly, so they generally flag left shifts for manual smear review. Blasts and circulating lymphoma cells are not part of the normal differential and, when detected, usually prompt further investigation.

Patterns of change

Neutrophilia is the most common cause of leukocytosis, and bacterial infection is its classic trigger, with inflammation and tissue injury as frequent contributors. Lymphocytosis is more typical of viral infections, while eosinophilia points toward allergic or parasitic conditions. These associations are general tendencies rather than rules. Early in some viral infections, neutrophils may briefly rise, and certain infections, such as pertussis and cat-scratch disease caused by Bartonella henselae, can produce marked lymphocytosis despite being bacterial.

The same patterns can arise from non-infectious causes. Corticosteroids and epinephrine redistribute neutrophils from the vessel walls into the circulation and can lower lymphocyte counts, producing the familiar "stress" profile of neutrophilia with lymphopenia. Physical exertion, emotional stress, pregnancy, smoking and lithium can also raise neutrophils. Myeloproliferative disorders and leukemia can produce extreme elevations, so a persistent or unexplained shift warrants further evaluation rather than attribution to a common cause. Because a high neutrophil-to-lymphocyte ratio is seen in infection, inflammation and stress alike, the differential alone rarely identifies a single cause, and its meaning depends on the clinical context and the trend over time.

Platelet Count and Platelet Indices

Platelets are small, anucleate fragments released from megakaryocytes in the bone marrow. When a vessel wall is damaged, they adhere to the exposed tissue, aggregate into a temporary plug, and expose a phospholipid surface on which clotting factors assemble. This makes them the main cellular agents of primary hemostasis. In a CBC the platelet count is commonly reported in thousands per microliter (×10^3/μL), which is numerically identical to ×10^9 per liter. An adult reference range of about 150 to 450 × 10^3/μL is typical. Circulating platelets survive roughly 7 to 10 days before they are cleared, and a meaningful fraction of the platelet pool is normally held in the spleen rather than circulating freely.

Platelet indices

The analyzer also reports indices derived from the platelet size histogram. Mean platelet volume (MPV), expressed in femtoliters, is the average size of the platelets counted. Typical values lie near 8 to 12 fL, but the figure depends on the instrument, so each laboratory usually sets its own range. Platelet distribution width (PDW) describes the spread of platelet volumes. Depending on the analyzer it is given as a coefficient-of-variation-type percentage or as a width measured at a fixed height of the distribution curve, so PDW values are not always comparable across machines. Some analyzers also report the platelet-large cell ratio (P-LCR), the proportion of platelets above a set size threshold.

These indices have clear limits. MPV tends to move inversely with the platelet count, so a low count can by itself shift MPV upward, and in a canine study neither MPV nor PDW helped distinguish the underlying disease process in thrombocytopenic animals. Larger, more reactive platelets are associated with faster production, consumption and activation, but size changes also arise from sample handling and from in vitro activation. Reported patterns are nonspecific: MPV is said to rise in many chronic conditions and fall in many acute ones, so these indices serve best as supporting information alongside the count and the smear.

Thrombocytopenia

Thrombocytopenia is generally defined as a count below 150 × 10^3/μL. Its causes are commonly grouped by mechanism.

Reduced production arises when the marrow fails to generate platelets. Examples include infiltration by leukemia, myelodysplastic syndromes, lymphoma or metastatic cancer; marrow suppression from chemotherapy, radiation or certain drugs; viral infections such as HIV, parvovirus, hepatitis C and Epstein-Barr virus; vitamin B12 or folate deficiency; alcohol use; and inherited syndromes such as Fanconi anemia and Wiskott-Aldrich syndrome.

Increased destruction or consumption occurs when platelets are removed from the circulation faster than they are replaced. Immune thrombocytopenia, in which antibodies target platelets, is the classic example, and heparin-induced thrombocytopenia arises from antibodies against complexes of platelet factor 4 with heparin. Thrombotic thrombocytopenic purpura, hemolytic-uremic syndrome, disseminated intravascular coagulation, sepsis and autoimmune disorders such as systemic lupus erythematosus and antiphospholipid syndrome can also drive consumption.

Sequestration and dilution form a third group. Enlargement of the spleen, as in hypersplenism, traps platelets and lowers the circulating count even when production is normal. Dilution follows large-volume transfusion, and pregnancy-related forms such as gestational thrombocytopenia and HELLP syndrome also belong here or to the destruction group, depending on the mechanism. Symptoms are usually absent when the count stays above about 50 × 10^3/μL, whereas counts between roughly 20 and 50 × 10^3/μL may cause petechiae, purpura or easy bruising.

Thrombocytosis

Thrombocytosis, a count above the upper reference limit (roughly 450 × 10^3/μL), has two broad categories. Reactive, or secondary, thrombocytosis is driven by cytokines released during inflammation, and it is seen with infection, iron deficiency, trauma, surgery, after splenectomy and in some malignancies. Clonal, or primary, thrombocytosis arises from myeloproliferative neoplasms such as essential thrombocythemia, in which driver mutations in genes such as JAK2, CALR and MPL cause the marrow to overproduce platelets. Distinguishing the two depends on clinical context, the smear, and in many cases molecular testing and marrow biopsy.

Pseudothrombocytopenia

Pseudothrombocytopenia is a spurious low count produced in the test tube rather than in the patient. The most common form is EDTA-dependent. EDTA binds calcium, which changes the shape of the platelet glycoprotein IIb/IIIa complex and exposes hidden epitopes. Naturally occurring IgG or IgM antibodies attach to these epitopes and bind platelets together. Clumps are counted as one or not at all, so the analyzer reports a falsely low count. Prevalence estimates vary between studies, from about 0.1 to 0.2 percent in the general population to higher figures in hospitalized patients, and the phenomenon is not linked to bleeding or platelet dysfunction.

Clues include a count out of proportion to the clinical picture, a histogram with an abnormal sawtooth pattern, and clumps seen on a stained smear. Repeating the test with a citrate or heparin tube usually resolves the problem, although a minority of patients clump in citrate as well. Recognizing the artifact matters because misreading it can lead to unnecessary investigations such as marrow biopsy, transfusions and treatment for immune thrombocytopenia.

Historical Development of Blood Counting

Before the mid-nineteenth century, blood was assessed mainly by its appearance and by clinical observation, with no practical way to count its cellular components. The first systematic method is usually attributed to Karl Vierordt, who in 1852 drew blood into a capillary tube, diluted a measured volume, and spread it on a slide. Cells were counted within a defined area under the microscope and the result was converted back to a number per unit volume of blood. The core logic, that a count is meaningful only relative to a known sample volume, still underlies every modern blood count reported per microliter or per liter.

Vierordt's spreading technique depended heavily on the operator, because the thickness and evenness of the film were hard to control. In 1874 Louis-Charles Malassez introduced the hemocytometer, a thick glass slide with a precisely ruled counting chamber of known depth. Diluted blood was loaded under a coverslip, so that the cells in a gridded area occupied a fixed, known volume. This geometry made manual red cell counts far more reproducible and became the standard reference approach for decades. The same kind of chamber is still used today for counting cells in other body fluids.

Counting alone could not say which cells were present. Paul Ehrlich, working in the late 1870s and 1880s, applied synthetic aniline dyes to tissues and blood, and found that different white cells took up acidic and basic dyes differently. This observation led to the classification of granulocytes into neutrophil, eosinophil and basophil types. In 1891 Dmitri Romanowsky reported a stain combining eosin and methylene blue, which colored nuclei and cytoplasm in contrasting tones. Later modifications of this principle, such as the Wright and Giemsa stains, became the basis of routine smear examination. Once cells in a smear could be recognized by lineage, a count could be divided into categories, which laid the groundwork for the differential count.

Red cell indices arose from a different line of work. Hemoglobin was originally estimated by visual comparison with colored standards, such as the acid hematin method associated with Hermann Sahli, but in the 1920s photoelectric colorimetry began to replace visual judgment and gave more objective values. In 1929 Maxwell Wintrobe described a graduated tube for measuring the hematocrit, the proportion of blood volume occupied by packed red cells after centrifugation. Combining the hematocrit with the red cell count and the hemoglobin concentration allowed clinicians to calculate the mean cell volume, the mean corpuscular hemoglobin, and the mean corpuscular hemoglobin concentration. Because these indices described the average size and hemoglobin content of red cells, they gave a way to characterize anemia beyond the simple total of red cells, and they remain calculated rather than directly measured values.

Automation transformed the field after the Coulter principle was patented. Wallace Coulter's patent, filed in 1949 and granted in 1953, described suspending particles in a conducting fluid and passing them through a small aperture, where each particle changes the electrical impedance in proportion to its volume. This allowed rapid counting and sizing of red cells and platelets, but distinguishing the five kinds of white cells was much harder. In the 1970s, the development of light-scattering and fluorescence-based flow cytometry made it possible to pass cells one at a time through a light beam, using their scatter and fluorescence signals to infer size, internal granularity and nucleic acid content. These approaches opened the way to automated differential counts, which later instruments extended and refined.

Analytical Technology of Modern Analyzers

Electrical impedance

The oldest principle still used in routine counting is electrical impedance, known as the Coulter principle. A diluted sample is drawn through a small aperture set between two electrodes. A cell crossing the opening briefly raises the electrical resistance of the path, and the size of each spike reflects how much conductive fluid the cell pushes aside. The number of pulses corresponds to the number of cells, and the height of each pulse is proportional to the volume of the cell. Dilution is essential because only a few cells pass through the aperture at once, so that each pulse can be attributed to a single cell. Aperture size is matched to the target population. The red blood cell and platelet aperture is smaller than the white cell aperture to increase platelet counting sensitivity.

Impedance alone sees size and nothing else. Cells such as nucleated red blood cells, platelet clumps, giant platelets or unlysed red cells cannot be separated by size and may interfere with the normal populations. This is why impedance is now usually combined with optical channels.

Optical methods and the differential

Optical channels use three measurements: forward scatter, which tracks cell size; side scatter, which reflects internal complexity such as nuclear shape and granularity; and fluorescence from dyes that bind nucleic acids. RNA and DNA dyes, such as propidium iodide or polymethine dyes, are commonly used and can separate nucleated red cells and reticulocytes from white cells, and also give information about cell viability. Some instruments first treat the sample with a chemical reagent so that the cells react before fluorescence flow cytometry is applied. Analyzing white blood cell differentials on certain hematology analyzers consists of a cytochemical reaction of the cells with specific reagents, followed by fluorescence flow cytometric analysis.

Differential designs have evolved in steps. Early automated instruments generated a three-part differential based on cell size, because normal samples generally produce three distinct peaks on a histogram. Five-part instruments combine several measurements to separate the white cells into neutrophils, lymphocytes, monocytes, eosinophils and basophils. The use of multiple methods by a given instrument for the determination of at least two cell properties allows the separation of white cells into a five-part differential. Six-part instruments add a further category, and the exact addition varies by manufacturer and channel design.

Hemoglobin, indices and output

Hemoglobin is measured photometrically after the red cells are lysed, so that the released pigment can be read by light absorbance. Several manufacturers now use cyanide-free SLS methods for measuring parameters rather than older cyanide-based reagents. Because the analyzer already knows hemoglobin concentration, the red cell count and an impedance-based cell volume, it can calculate the indices: mean corpuscular volume from the volume measurement, and mean corpuscular hemoglobin and its concentration from the ratios of hemoglobin to cell count and to hematocrit. The instrument then reports the counts, indices and differential from these independent channels, which allows internal cross-checks.

Reticulocyte counting relies on the same optical logic. The XE series and the newest XN series also provide a fully automated reticulocyte count. Dyes that bind RNA label these immature red cells, and their fluorescence is measured separately from mature erythrocytes.

Automated classification and flagging

Newer analyzers use trained algorithms to assign cells to categories from their scatter and fluorescence patterns. When a sample produces clusters that fall outside expected regions, or when the pattern suggests an abnormal cell, the instrument issues a flag. Flags direct the sample to manual smear review. Machine-learning approaches are being used to improve this classification, but their performance depends on the training data and on the specific instrument, so results and flag rules differ between manufacturers.

Specimen Collection, Quality Control and Smear Review

Most CBC specimens are venous blood drawn into tubes coated with EDTA, a chelating anticoagulant. EDTA is a widely used anticoagulant in lavender or pink-top tubes for hematology testing. It preserves blood cells by binding calcium, preventing clotting. In some settings, particularly pediatric and point-of-care work, a capillary sample from a fingerstick or heel prick is used instead, because conventional analyzers require specialized infrastructure and trained personnel, limiting access. Validation of capillary testing therefore compares paired venous and capillary results, usually with Passing-Bablok regression and Bland-Altman plots generated for each CBC analyte.

Many errors occur before the tube reaches the analyzer. When a tube is underfilled, the ratio of anticoagulant to blood rises and red cells shrink, so the measured hematocrit reads low. Underfilling can also depress MCV and MCH. Inadequate inversion allows microclots to form, which distort platelet and white cell counts. Clotted specimens are generally unusable: automated cell counters cannot count cells in clotted specimens, and the specimen will be rejected. The patient needs to be redrawn. Hemolysis lowers the red cell count and hematocrit while raising MCHC, because released hemoglobin is measured in the same sample. Delay also matters, since leukocytes degrade and platelets swell over time. Sources disagree on the acceptable window: one suggests processing within 6 hours, while another proposes within 2 hours of collection, so laboratories set their own limits. Storage that is too long can falsely raise MCV, and sample temperature before analysis is listed among the causes of spurious results.

Analyzers are calibrated against defined materials and monitored with commercial control material. In the NHANES program, for example, a set of cell controls with normal and two abnormal levels was used to monitor CBC and differential parameters, and calibrators were run before patient testing. The NHANES laboratory protocol applied Westgard rules, a set of statistical criteria for detecting analytical shifts. Specimens are measured in duplicate as a safeguard against random error: In the MEC, the CBC results are measured in duplicate and averaged. The averaged results are reported to participant and released in this dataset. The survey's quality assurance protocols were also designed to meet the requirements of the 1988 Clinical Laboratory Improvement Amendments, and laboratory staff competence was assessed through observation and periodic retraining.

When an analyzer detects a result it cannot classify with confidence, it attaches a flag. Such flags typically signal an atypical white cell population, nucleated red cells, platelet clumps, or unusual cell sizes. A technologist then prepares a thin, stained blood film and examines it under a microscope. The smear remains the reference for confirming abnormal cells, nucleated red cells and platelet morphology, such as giant or clumped platelets, that automated counts cannot reveal.

Before a new analyzer is adopted, laboratories compare its output with a reference instrument using paired patient samples. Common statistical approaches include ordinary least squares, Passing-Bablok, and Deming regression, supplemented by Bland-Altman analysis. Regression reveals constant and proportional bias, whereas Bland-Altman analysis expresses agreement as a mean difference with limits of agreement calculated as mean bias ±1.96 SD. Some CLSI-based comparisons classify the resulting bias into categories, with the best agreement at the top of the scale.

Results between brands are often close but not identical. One comparison of Mindray and Sysmex instruments reported correlation coefficients above 0.98 for the main parameters, yet more than 95% of the points within the 95% consistency limit was not met for every parameter. Another study found statistically significant differences for four hematological parameters: eosinophil count, immature granulocytes, mean corpuscular hemoglobin concentration (MCHC) and platelet distribution width (PDW). Differences arise from distinct measurement principles, calibration schemes, reagents, and maintenance needs, so a result from one instrument is not automatically interchangeable with another's.

Reference Intervals and Interpreting Results

How reference intervals are set

Each CBC parameter is compared with a reference interval, which by convention covers the central 95% of results from a healthy reference population. The remaining 5% is split between the two extremes, with 2.5% at each end. Guidance from the Clinical and Laboratory Standards Institute (CLSI) describes this as a three-step process of partitioning, outlier elimination and calculation. Partitioning means that the reference data are first separated into age and sex groups. Nonparametric methods, which rank the values and cut at the 2.5th and 97.5th percentiles, are the original recommended approach. A figure of around 120 healthy individuals is often cited as a practical minimum, although larger sample sizes provide more reliable data.

Why reference values vary

Reference values depend on the population and the analytical method. Reference values differ according to many socio-demographic characteristics, and factors such as age, gender, diet, ethnicity and altitude affect the ranges for different groups. Age is especially important in childhood, because blood counts change along the maturation process from fetal to adult erythropoiesis. Newborns can have white cell counts far above adult values, 13,000 to 38,000 cells/µL, while adults sit at 4,500 to 11,000 cells/µL. Sex differences are most visible in red cell parameters: some references give hemoglobin of 11.5 to 15.5 g/dL for females and 13 to 17 g/dL for males, though some references have male and female reference ranges, based on typical levels of hormones by sex. Sex differences are not uniform, however. A study of Ghanaian children found no statistically significant differences in most CBC parameters by sex, and it also found clear differences from the manufacturer's ranges. This shows why many laboratories verify or derive local intervals rather than adopting published ones. Some analytes are managed by national decision limits instead of statistical intervals, but the statistical approach remains the default for most CBC values.

What an out-of-range result does and does not mean

Because the interval is defined by a fixed percentage, a predictable share of healthy people will fall outside it. By definition, 5% of normal, healthy people will have an abnormal result. A related misconception is that most people with a given disease will have results outside the interval; in practice this is rarely true. A value just beyond a limit is therefore weak evidence on its own. Small deviations are common, and a result that is consistently slightly low may simply reflect an individual's stable baseline. Repeat measurement and comparison with the patient's previous results usually carry more information than a single value against a population range. A falling platelet count from a previously normal level, for example, deserves more attention than an isolated borderline value of the same size.

Reading parameters as patterns

The three main red cell measurements (red cell count, hemoglobin and hematocrit) are physically linked, so they should move together. Discordance between them can indicate a technical problem, and the red cell indices (described in the section on red cell parameters) are used together to define anemia profiles, such as small cells with low hemoglobin or large cells with low hemoglobin. Pancytopenia is a pattern in which the red cell, white cell and platelet lines are all reduced. It is a pattern rather than a single diagnosis, and it prompts a search for marrow failure, marrow infiltration or drug or nutritional causes, often with a bone marrow examination. Reading the whole panel in this way is more informative than assessing each value in isolation.

Biological variation and multiple testing

Within the same person, CBC values fluctuate around a personal set point. For many hematological parameters, the variation between individuals is larger than the variation within one person, so a value that is typical for a population may be unusual for a given patient, and vice versa. A reference interval describes the population, not the individual.

Multiple testing adds a further problem. If $N$ independent tests are performed on a healthy person, the chance of at least one abnormal result is $1-0.95^{N}$. If 20 tests are done on a normal, healthy person, one of the results is expected to fall outside the normal range. By calculation, the probability of at least one abnormal result with 20 tests is about $1-0.95^{20}\approx 0.64$. The risk of spurious abnormal results reaches close to 50% when N is 13. The formula assumes independence, which real parameters lack. In many situations the assumptions are not met and the formula overestimates the occurrence of abnormal results in healthy populations. Correlated indices such as hemoglobin, hematocrit and red cell count are not independent, which partly offsets the effect. For this reason, just one value outside the 95% limit would not usually be considered to be statistically significant when multiple tests were carried out. Interpreting an isolated borderline result therefore calls for clinical context, repetition and judgment rather than automatic follow-up, a principle that connects to statistical reasoning and to evidence-based practice.

Clinical Uses in Screening, Diagnosis and Monitoring

Screening and preoperative assessment

Because one specimen yields information about red cells, white cells and platelets at once, the CBC is attractive as a screen. Guidance on use in people without symptoms is more restrained. Clinical practice guidance generally discourages ordering it as a routine step for people without symptoms, favoring it instead when someone has a history of anemia or hematologic or liver disease, when a physical examination suggests anemia, or when a chronic condition linked to anemia is present.

In the preoperative setting, the justification is largely risk-based. A complete blood count is indicated for patients with diseases that increase the risk of anemia or patients in whom significant perioperative blood loss is anticipated. By contrast, baseline laboratory studies in patients without significant systemic disease undergoing low-risk surgery should not be obtained when significant blood loss or fluid shifts are not expected. Correcting abnormal counts before an operation is also increasingly framed as a way to reduce transfusion needs. Developing individualized strategies that focus on correcting preoperative complete blood count abnormalities and minimizing transfusion requirements are considered essential.

Diagnosis

The panel rarely establishes a diagnosis on its own; it more often directs the next step. Its parameters help professionals look for signs of infection, anemia and other disorders. A low hemoglobin prompts calculation of the red cell indices and, often, iron or vitamin B12 studies. Raised neutrophil or lymphocyte counts, together with clinical findings, point toward infection or inflammatory processes. Circulating blasts or a markedly abnormal leukocyte pattern raise concern for leukemia or lymphoma, which typically require bone-marrow sampling, flow-cytometry and sometimes a biopsy. Low platelet counts, read alongside coagulation tests, help evaluate bleeding and clotting disorders.

Monitoring myelosuppressive treatment

Most of the CBC's routine use in treatment settings concerns chemotherapy. Myelosuppression results from chemotherapy-induced damage to hematopoietic stem cells. Counts therefore fall in a predictable sequence: the neutrophil nadir is anticipated between 5 and 10 days after drug administration, and platelet counts may be lowest up to 14 days after treatment. Treatment decisions rely on thresholds. For docetaxel, the label requires an absolute neutrophil count of at least 1.5 × 10^9 cells/L before each dose. Prior to each administration of cytotoxic drugs, the absolute neutrophil count is measured to confirm adequate levels. Trial protocols may tighten monitoring further; one pediatric neuroblastoma protocol, for example, calls for a CBC to be checked twice weekly for patients with Grade 4 thrombocytopenia or Grade 4 neutropenia.

Practice is not uniform. In one breast cancer trial, a questionnaire completed by 23 sites found that most of them checked counts once or twice during the first treatment cycle. The same test is used for people taking drugs known to lower white cell counts, where the provider will likely perform the test regularly to monitor neutrophil levels. The clinical frequency is set by the drug's known toxicity and the patient's course rather than by a fixed schedule.

Public health and epidemiology

Hemoglobin concentration, the most widely measured CBC component, underpins population estimates of anemia. The World Health Organization recommends the use of hemoglobin concentrations to estimate the population prevalence of anemia. The cut-offs for different groups were set earlier: thresholds for normal hemoglobin in children, adolescents, adults and pregnant women were defined at a WHO Expert Consultation in Geneva in 1992. Those thresholds have since been revised, and the effect is measurable. In an Indian analysis, anemia prevalence during pregnancy decreased from 52.2% as per the previous cutoff to 47.1% as per the revised cutoff.

Survey results also depend on measurement conditions. Analyses of five US survey cycles from 2003 to 2012 estimated that an average of 5.6% of the U.S. population met the criteria for anemia and 1.5% for moderate-severe anemia during this 10-year period. Estimates can shift with specimen and method: they are affected by the use of venous or capillary specimens, the instrument used to assess hemoglobin, season of measurement, iron supplementation, and the prevalence of alpha thalassemia. National programs therefore use a reference method; China's surveys, for instance, relied on the cyanmethemoglobin method, which is recommended by the International Committee for Standardization in Hematology. Trends in such surveys can run in opposite directions across countries and periods, as in China, where child and adolescent anemia decreased from 12.6% to 6.6% between 2002 and 2010–2012, while India's national survey data show an upward trajectory over the same decade.

Relationship to Other Blood and Marrow Tests

A CBC rarely settles a diagnosis alone. Its numbers usually point toward the next test, which depends on which lineage is affected. A peripheral blood smear is often the first follow-up. A pathologist examines stained cells under a microscope and judges their size, shape and maturity, which can reveal abnormalities that an automated analyzer misclassifies or does not flag. When the findings suggest a marrow problem, such as low counts in several lineages or circulating blasts, bone marrow aspiration and biopsy sample the cells that produce blood directly. Pancytopenia and peripheral blasts suggest acute leukemia.

The reticulocyte count is often ordered alongside a CBC when anemia is present, because it shows how actively the marrow is releasing new red cells. Reticulocytes keep a small amount of residual RNA and lose it within about a day of entering the bloodstream, so the count reflects recent production rather than stored cells. Anemia lowers the number of red cells, which can make the reticulocyte percentage look falsely high. A corrected reticulocyte count adjusts for this effect and allows marrow output to be assessed.

Once the red cell indices suggest a pattern, follow-up testing aims at the underlying cause. The CBC's red cell indices can classify anemia further and suggest which additional tests are needed. A low mean corpuscular volume typically prompts iron studies, such as ferritin and transferrin saturation, and, when iron stores are adequate, evaluation for thalassemia. A high mean corpuscular volume directs attention to vitamin B12 and folate levels. When hemolysis is suspected, clinicians add tests such as haptoglobin and a direct antiglobulin test.

Inflammatory markers are frequently ordered together with the CBC, particularly when infection, autoimmune disease or vasculitis is considered. The erythrocyte sedimentation rate (ESR) is measured by the Westergren method, in which the height of the plasma column is read after one hour in a narrow tube. Its upper limit depends on age and sex. A high ESR indicates an inflammatory state without prejudging its nature. The C-reactive protein (CRP), made by the liver, is an inflammation marker that responds faster and more sensitively to acute change. CRP rises quickly and falls fast, whereas ESR rises and falls more slowly. Neither test identifies a specific disease, so both are interpreted in clinical context alongside the CBC.

When an abnormal CBC raises concern for leukemia or lymphoma, classification depends on further laboratory work. Flow cytometric immunophenotyping uses fluorescent antibodies against surface and intracellular markers to determine the lineage and maturation stage of the abnormal cells. Cytogenetic and molecular genetic tests then look for chromosomal translocations and gene mutations that define specific subtypes. Together with cell morphology from the smear and marrow, these results determine the diagnosis of leukemia or lymphoma and guide treatment decisions.

Limitations, Current Developments and Open Issues

Automated analysis has clear limits. Analyzers sort cells by size, internal complexity and fluorescence, and they can misidentify abnormal or immature cells. One review of smear practice notes that this is required in 10%–50% of samples due to uncertainties in cell identification as flagged by the hematology analyzer. The workload varies by laboratory. A Canadian survey reported review rates of 11%–20% among the majority (90%) of surveyed institutions, while an Ontario survey found that most laboratories kept technologist review at or below 15%. Flagging rules also differ between instruments and institutions. Flagging is imperfect in other ways too: most automated hematology analyzers cannot distinguish small lymphoid blasts, circulating small lymphoma cells, and normal lymphocytes, which is why abnormal lymphoid populations can escape detection. Analyzers are also costly and technically demanding to install, calibrate and maintain, which limits their use in small or resource-poor laboratories.

Point-of-care cell counters extend testing to clinics, emergency departments and field settings without central laboratories. Their accuracy depends on the analyte. One review found that leading PoC devices perform very well, with high correlation for white blood cells, red blood cells and platelets when compared to large laboratory machines, but some devices report lower monocyte counts or show slight dips in hematocrit and MCV levels compared to reference methods. White cell counts from capillary samples are less reliable. In a pediatric study, POC WBC testing was considered unreliable, with discrepancies between the results from capillary and venipuncture sampling, consistent with earlier studies showing lower counts from capillary samples. Point-of-care hemoglobin devices have also shown systematic underestimation, and one comparison concluded that all 3 POCT devices underestimated the laboratory hemoglobin and cannot be used interchangeably with standard laboratory measurements.

Standardization efforts aim to give manufacturers and laboratories a common reference. The traditional reference for the differential is manual: two reviewers each counting 200 cells, as outlined in CLSI H20-A2, first approved in 1992 and revised in 2007. The International Council for Standardization in Hematology (ICSH) has proposed a flow cytometric reference method. Its authors reported equivalent performance between the flow cytometric method and the current manual reference method, with improved performance for low or infrequent populations such as monocytes and basophils, and they suggested it could be used in lieu of CLSI H20‐A2 as a reference for white blood cell enumeration and differential counting. Harmonizing results across analyzers for parameters such as eosinophils, MCHC and PDW remains an active task, because each instrument family defines and measures these quantities through its own channels and algorithms.

Artificial intelligence is being applied to decide which smears need human review. One study of machine-learning criteria applied to 13298 samples analyzed at 15 different laboratories reported 79.3% sensitivity for abnormal smears, with a target that false-negative rates stay below 5%. Whether such models should replace rule-based flags, and how their performance should be validated across instruments and populations, is still debated. Related evidence questions the value of reviewing every flagged sample: one single-center study concluded that routine smear review of all flagged samples do not contribute with additional, significant information. This points toward more selective review, though it does not settle how selective review should be designed.

Two further questions remain open. The first concerns reference limits. Intervals are usually drawn from population data, but whether lower and upper limits should be set more narrowly by age, sex, ethnicity or analytical method is still under discussion. The second concerns whether patient-specific baselines, in which each person's previous results serve as the reference, should supplement or replace population intervals. Serial measurements could reveal meaningful change in individuals whose values sit within the population range, but the statistical rules for judging such change, and their clinical benefit, are not yet settled.

References

1. Complete Blood Countencyclopedia.com
2. Complete Blood Count (CBC): What It Is & Normal Rangesmy.clevelandclinic.org
3. White Blood Cell Count - Complete Blood Count - Lab Test Results Interpretationtestresult.org
4. Complete Blood Count (CBC) Testwebmd.com
5. Red Cell Indices - Clinical Methods - NCBI Bookshelfncbi.nlm.nih.gov
6. Hematology White Paper - The Influence of RBC Counting Technology on MCHC Resultssysmex.com
7. Red blood cell indicesen.wikipedia.org
8. RBC Indices Calculatoromnicalculator.com
9. Red Blood Cell (RBC) Indices Calculatormdapp.co
10. Quiz 1 - Red Cell Indices • The Blood Projectthebloodproject.com
11. Statistical haemoglobin thresholds to define anaemia across the lifecyclemedrxiv.org
12. Haemoglobin thresholds to define anaemia from age 6 months to 65 years: estimates from international data sourcesncbi.nlm.nih.gov
13. Variation Patterns of Hemoglobin Levels by Gestational Age during Pregnancy: A Cross-Sectional Analysis of a Multi-Center Retrospective Cohort Study in Chinancbi.nlm.nih.gov
14. Red blood cell distribution widthen.wikipedia.org
15. Anisocytosisen.wikipedia.org
16. A-146 A Review of RDW-CV and RDW-SD Measurements in Patients With Iron Deficiency Anemia in an Acute Care Hospital in Singaporeacademic.oup.com
17. Red Cell Distribution Width (RDW) Test: Interpretation of the Red Cell Distribution Width Test, Collection, and Panels: Overview, Interpretation of the Red Cell Distribution Width Test, Collection and Panelsemedicine.medscape.com
18. Red Cell Distribution Width (RDW) • The Blood Projectthebloodproject.com
19. Leukocyte Count (WBC): Reference Range, Interpretation, Collection and Panelsemedicine.medscape.com
20. Differential Blood Count: Reference Range, Interpretation, Collection and Panelsemedicine.medscape.com
21. Blood differential testucsfhealth.org
22. Blood tests and urinalysislls.org
23. Evaluation of Patients with Leukocytosisaafp.org
24. White blood cell differentialen.wikipedia.org
25. White Blood Cell Count: Normal, High, and Low Countshealthline.com
26. Complete Blood Count (CBC)iapac.org
27. Neutrophilia - an overviewsciencedirect.com
28. Leukocytosis: Background, Pathophysiology, Epidemiologyemedicine.medscape.com
29. Leukocytosis - StatPearls - NCBI Bookshelf - NIHncbi.nlm.nih.gov
30. High Neutrophil Symptoms: Causes, Signs & What They Meanmitohealth.com
31. Bandemia: What is it and Why is it Important?labmedicineblog.com
32. Beyond Bands: The Immature Granulocyte Countlabmedicineblog.com
33. Comparison of Band Percentage vs Immature Granulocyte Percentage in the Setting of Possible Infection Principle Investigators - PMCpmc.ncbi.nlm.nih.gov
34. Thrombocytopenia: Evaluation and Managementaafp.org
35. Thrombocytopenia (Low Platelet Count): Causes and Symptomsmedicinenet.com
36. Platelet disorderslifeblood.com.au
37. Overview of Platelet Disorders - Hematology - Merck Manual Professional Editionmerckmanuals.com
38. Production of red blood cells and platelets from stem cellsimage-ppubs.uspto.gov
39. Mean Platelet Volume • The Blood Projectthebloodproject.com
40. Platelet distribution width and mean platelet volume in the interpretation of thrombocytopenia in dogsresearchgate.net
41. Platelet Distribution Width - an overviewsciencedirect.com
42. Mean Platelet Volume and Platelet Distribution Width as Markers in the Diagnosis of Acute Gangrenous Appendicitis - PMCpmc.ncbi.nlm.nih.gov
43. The Phantom Platelet Problem: Unmasking Ethylenediaminetetraacetic Acid (EDTA)-Induced Pseudo-Thrombocytopeniancbi.nlm.nih.gov
44. Pseudothrombocytopenia due to Platelet Clumping: A Case Report and Brief Review of the Literaturencbi.nlm.nih.gov
45. Ethylene Diamine Tetra Acetate-Induced Pseudo Thrombocytopenia (EDTA-PTCP) in an Adolescent: A Case Reportncbi.nlm.nih.gov
46. Pseudothrombocytopenia - an overviewsciencedirect.com
47. EDTA-dependent pseudothrombocytopenia - ScienceDirectsciencedirect.com
48. Pseudothrombocytopenia and other conditions associated with spuriously low platelet countshaematologica.org
49. Platelet Clumping Protocolohsu.edu
50. Pseudothrombocytopenia induced by EDTA and chronic inflammatory demyelinating polyneuropathyscielo.sa.cr
51. White Blood Cell Counts Reference Methodologythebloodproject.com
52. Principles of Working of Automated Hematology Analyzerbioscience.com.pk
53. Automated Cell-Counting Instrumentationoncohemakey.com
54. Optimizing Optical Technology for Automated Hematology Analyzerstechnologynetworks.com
55. Counting White Blood Cells • The Blood Projectthebloodproject.com
56. Automated blood cell analysis - Rodak's Hematology Clinical Principles and Applicationsdoctorlib.org
57. Buyer's Guide: Hematology Analyzer Comparison for Clinical Laboratoriesaxoniamedical.com
58. Multisizer 4e Coulter Counterbeckman.com
59. Cell Counters, Sizers and Media Analyzersbeckman.com
60. Preanalytical Errors in EDTA Samplesedtatube.com
61. Clinical validation of the Hilab lens for AI supported point of care CBC testing in pediatric oncologynature.com
62. The Order of Draw Series: Part Five - EDTA Tubesphlebotomy.com
63. Pre-analytical errors in hematology: Small mistakes that skew big results - LaboratoryInternlaboratoryintern.com
64. Table of Contentswwwn.cdc.gov
65. Analytical Verification and Method Comparison of the Atellica HEMA 580 Hematology Analyzer for Routine Clinical Laboratory Implementation in a Tertiary Care Setting - PMCpmc.ncbi.nlm.nih.gov
66. Analytical comparison between two hematological analyzer systems: Mindray BC‐5180 vs Sysmex XN‐1000ncbi.nlm.nih.gov
67. A comparison of Sysmex-XN 2000 and Yumizen H2500 automated hematology analyzersncbi.nlm.nih.gov
68. Navigating Spurious Results on CBC/Chemistryelliediagnostics.com
69. Performance evaluation of the new Dymind automated hematology analyzer - ScienceDirectsciencedirect.com
70. Table of Contentswwwn.cdc.gov
71. 7-1 Laboratory Procedure Manual Analyte: Complete Blood Count Matrix:wwwn.cdc.gov
72. NHANES 2015-2016: Complete Blood Count with 5-Part Differential - Whole Blood Data Documentation, Codebook, and Frequenciesdata.nber.org
73. Table of Contentswwwn.cdc.gov
74. Full article: Laboratory reference intervals - history and modern approaches for improved utilitydoi.org
75. An Investigation into Outlier Elimination and Calculation Methods in the Determination of Reference Intervals using Serum Immunoglobulin A as a Model Data Collectionarxiv.org
76. Reference Ranges: Impact on Lab Results and Carecentradiagnostics.com
77. Reference values of Complete blood count in healthy adult Eritreanmedrxiv.org
78. Reference ranges for complete blood count in children and adolescents with Down syndromencbi.nlm.nih.gov
79. WBC Normal Range by Age (and Sex): Reference Values Chart - Vital Signs Todaymedicalnewstoday.us
80. Complete Blood Count Reference Intervals for Children Aged Less Than 1 to 12 Years in the Northern Region of Ghanancbi.nlm.nih.gov
81. Interpretating Normal Values and Reference Ranges for Laboratory Tests - PMCpmc.ncbi.nlm.nih.gov
82. Blood tests – too much of a good thingncbi.nlm.nih.gov
83. Multi-test screening and the chances of being normal - PubMedpubmed.ncbi.nlm.nih.gov
84. When is “abnormal” abnormal? Dealing with the slightly out of range laboratory result - PMCpmc.ncbi.nlm.nih.gov
85. Reference Intervals: Practical Aspects - PMC - NIHpmc.ncbi.nlm.nih.gov
86. Why "Abnormal" Lab Results Don't Always Mean Something Is Wronghealthed4everyone.org
87. Preoperative investigations for elective surgical patients in a resource limited setting: Systematic review - PMCpmc.ncbi.nlm.nih.gov
88. Preoperative Testing Before Noncardiac Surgery: Guidelines and Recommendationsaafp.org
89. Preoperative Testing - an overviewsciencedirect.com
90. Preoperative consultation for determining the appropriate transfusion strategyncbi.nlm.nih.gov
91. Monitoring of Chemotherapy Patients in General Practicetodaysveterinarypractice.com
92. Model-based prediction of myelosuppression and recovery based on frequent neutrophil monitoringncbi.nlm.nih.gov
93. High-Risk Neuroblastoma Chemotherapy Without G-CSFcdn.clinicaltrials.gov
94. Neutropenia: What it Is, Types, Symptoms & Causesmy.clevelandclinic.org
95. Comparing hemoglobin distributions between population-based surveys matched by country and timencbi.nlm.nih.gov
96. WHO Global Database on Anemia, Nutrition Landscape Information Systemghdx.healthdata.org
97. Trends in Anemia Prevalence Among Indian Women Using Revised WHO Hemoglobin Cutoffs: Insights From Repeated Cross-Sectional Surveys (1998–2019)ncbi.nlm.nih.gov
98. The Prevalence of Anemia and Moderate-Severe Anemia in the US Population (NHANES 2003-2012)ncbi.nlm.nih.gov
99. Prevalence of Anemia in Chinese Children and Adolescents and Its Associated Factorsncbi.nlm.nih.gov
100. Systems and methods for sample display and reviewimage-ppubs.uspto.gov
101. Induced Myelosuppression and Recommendation for Monitoring of Absolute Neutrophil Counts in Patients Treated with Epirubicin and Cyclophosphamide in Early Breast Cancer: Results from a Phase 2a Collaborative Trial of the AGO-B and CESAR Study Groupsashpublications.org
102. Hemoglobin levels for determining anemia: new World Health Organization guidelines and adaptation of the national standardncbi.nlm.nih.gov
103. Dosing parameters for CD47 targeting therapies to hematologic malignanciesimage-ppubs.uspto.gov
104. Anemiaarupconsult.com
105. Device and method for performing a complete blood count and determining a sedimentation rateimage-ppubs.uspto.gov
106. High ESR and CRP Together: Urgent Signs You Shouldn't Ignoreubiehealth.com
107. Reticulocyte Count Blood Test: Order & Check Resultstesting.com
108. Evaluation of Anemia - Hematology - Merck Manual Professional Editionmerckmanuals.com
109. ESR vs. CRP: Blood Tests for Detecting Inflammationmedcentral.com
110. Biomarkers and methods for measuring and monitoring inflammatory disease activityimage-ppubs.uspto.gov
111. White Blood Cell Enumeration and Differential by Flow Cytometry: The ICSH WBC Reference Methodncbi.nlm.nih.gov
112. Performance of Automated Hematology Analyzer Criteria in Detecting Peripheral Blood Smear Abnormalities: A Systematic Literature Review - PMCpmc.ncbi.nlm.nih.gov
113. Preparing blood smears on a fiber surfaceimage-ppubs.uspto.gov
114. Continuous Blood Monitoring with Particle-based Integrated Sensing and Communication (ISAC)arxiv.org
115. Comparison between point‐of‐care testing from capillary samples and conventional laboratory testing from venous samples for white blood cells and C‐reactive protein in a pediatric outpatient setting - PMCpmc.ncbi.nlm.nih.gov
116. Comparison of Hemoglobin Measurements by 3 Point-of-Care Devices With Standard Laboratory Values and Reliability Regarding Decisions for Blood Transfusion - PubMedpubmed.ncbi.nlm.nih.gov
117. White Blood Cell Enumeration and Differential by Flow Cytometry: The ICSH WBC Reference Method - Hedley - 2026 - International Journal of Laboratory Hematology - Wiley Online Libraryonlinelibrary.wiley.com
118. Development of criteria to optimize manual smear review of automated complete blood counts using a machine learning model - PMCpmc.ncbi.nlm.nih.gov
119. Clinical value of smear review of flagged samples analyzed with the Sysmex XN hematology analyzerdoi.org